Cargando…
Serum biomarkers in myelin oligodendrocyte glycoprotein antibody–associated disease
OBJECTIVE: To test the hypothesis that the pattern of serum biomarkers of disease activity and disability in myelin oligodendrocyte glycoprotein antibody–associated disease (MOGAD) will be different from those in neuromyelitis optica spectrum disorder (NMOSD) with anti–aquaporin-4 antibodies (AQP4-A...
Autores principales: | Kim, Hyunjin, Lee, Eun-Jae, Kim, Seungmi, Choi, Lyn-Kyung, Kim, Keonwoo, Kim, Hye Weon, Kim, Kwang-Kuk, Lim, Young-Min |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7136043/ https://www.ncbi.nlm.nih.gov/pubmed/32184342 http://dx.doi.org/10.1212/NXI.0000000000000708 |
Ejemplares similares
-
Clinical implication of serum biomarkers and patient age in inflammatory demyelinating diseases
por: Lee, Eun‐Jae, et al.
Publicado: (2020) -
Clinical characteristics of myelin oligodendrocyte glycoprotein antibody-associated disease according to their epitopes
por: Seok, Jin Myoung, et al.
Publicado: (2023) -
Seroprevalence of anti‐myelin oligodendrocyte glycoprotein antibodies in adults with myelitis
por: Kim, Ki Hoon, et al.
Publicado: (2022) -
New-onset epilepsy in a patient with myelin oligodendrocyte glycoprotein antibodies
por: Im, Hansol, et al.
Publicado: (2021) -
Clinical and Radiological Features of Myelin Oligodendrocyte Glycoprotein-Associated Myelitis in Adults
por: Kim, Ki Hoon, et al.
Publicado: (2022)